Keyphrases
P-glycoprotein (P-gp)
100%
Flavonoid Monomer
68%
Multidrug Resistance
49%
Drug Resistance
40%
Multidrug Resistance Protein 1 (MDR1)
34%
Flavonoids
32%
Cancer Cells
23%
Multidrug Resistance Reversal
23%
Leishmania
21%
Overexpressing
20%
In Cancer
20%
Synthetic Flavonoid
20%
P-glycoprotein Inhibitor
19%
Gleditsia Sinensis
18%
Homodimer
18%
EC50
18%
Structure-activity Relationship
18%
Xenograft
17%
Vinblastine
16%
Breast Cancer Resistance Protein
16%
Apigenin
16%
Paclitaxel
15%
Multidrug Resistance in Cancer
14%
Fruit Extract
14%
Protease Inhibitors
13%
Inhibitory Activity
13%
Amines
13%
IC50
13%
Cancer Cell Lines
12%
Modulating Activity
12%
Pichia Pastoris
11%
Chemosensitizer
11%
Pentamidine
11%
Breast Cancer Cells
11%
Cytotoxicity
11%
Doxorubicin
11%
Drug Accumulation
10%
Epigallocatechin Gallate
10%
Triazole
10%
Catechin
10%
ATP-binding Cassette Transporter A1 (ABCA1)
10%
Anticancer Drugs
10%
Leishmania Enriettii
10%
ABCG2
9%
ABCC1
9%
Overexpression
9%
Plasmodium Falciparum
9%
Linker
9%
Cutaneous Leishmaniasis
9%
Resistant Cancer Cells
9%
Pharmacology, Toxicology and Pharmaceutical Science
Flavonoid
74%
Multidrug Resistance
71%
Dimer
64%
Malignant Neoplasm
64%
P-Glycoprotein
49%
Drug Resistance
48%
Breast Cancer
27%
ABCG2
27%
Paclitaxel
25%
Structure Activity Relationship
23%
Gleditsia
18%
Leishmania
17%
Multidrug Resistance Protein 1
15%
Leukemia
15%
Neoplasm
14%
Glycoprotein P Inhibitor
14%
Cytotoxicity
12%
EC50
12%
IC50
11%
Pentamidine
11%
Effusion
11%
Doxorubicin
11%
Apigenin
10%
Natural Product
10%
Triazole
10%
Homodimer
9%
Polyphenol
9%
Epigallocatechin
9%
Proteasome Inhibitor
9%
Skin Leishmaniasis
9%
Amastigote
8%
Verapamil
8%
Vinblastine
8%
Synapsin I
8%
ABC Transporter
8%
Proteasome
8%
Solid Malignant Neoplasm
7%
Vincristine
7%
Infection
7%
Epigallocatechin Gallate
7%
Catechin
6%
Pharmacokinetics
6%
Epicatechin
6%
Diseases
6%
Macrogol
6%
Bioavailability
6%
Protozoon
5%
Antiproliferative Activity
5%
Acute Myeloid Leukemia
5%
Leishmania enriettii
5%